Cardiac extracellular matrix: A dynamic entity

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 3 58-3, 2005, Pages

  Brown, Lindsay ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ATRASENTAN; COLLAGEN; COLLAGEN FIBRIL; CYTOKINE; DEOXYCORTICOSTERONE ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELASTIN; ENDOTHELIN; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; FIBRILLAR COLLAGEN; FIBRILLIN; FIBRILLIN 1; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; GROWTH FACTOR; LISINOPRIL; LOSARTAN; MATRIX METALLOPROTEINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SESAMIN; STRUCTURAL PROTEIN; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; BIOENGINEERING; CONTROLLED STUDY; DIABETES MELLITUS; EDITORIAL; EXTRACELLULAR MATRIX; FIBROBLAST; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE NECROSIS; HYPERTENSION; INFLAMMATORY CELL; MACROPHAGE; MARFAN SYNDROME; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TENSILE STRENGTH;

ANIMALS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HEART; HUMANS; MYOCARDIUM;

EID: 23944522286     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00443.2005     Document Type: Editorial

References (22)

1. A receptors. Hypertension 39: 679-684, 2002.
2. Bouzeghrane F, Reinhardt DP, Reudelhuber T, and Thibault G. Enhanced expression of fibrillin-1, a constituent of the myocardial extracellular matrix, in fibrosis. Am J Physiol Heart Circ Physiol 289: H982-H991, 2005.
3. Brilla CG, Funck RC, and Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 102: 1388-1393, 2000.
4. Brown L, Duce B, Miric G, and Sernia C. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system. J Am Soc Nephrol 10: S143-S148, 1999.
5. Brown L, Chan V, and Fenning A. Targets for pharmacological modulation of cardiac fibrosis. In: Interstitial Fibrosis in Heart Failure, edited by Villarreal FJ, 2005, New York: Springer, p. 275-310.
6. Brown RD, Ambler SK, Mitchell MD, and Long CS. The cardiac fibroblast: therapeutic target in myocardial remodelling and failure. Ann Rev Pharmacol Toxicol 45: 657-687, 2005.
7. A receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension. Hypertension 42: 811-817, 2003.
8. Dokos S, Smaill BH, Young AA, and LeGrice IJ. Shear properties of passive ventricular myocardium. Am J Physiol Heart Circ Physiol 283: H2650-H2659, 2002.
9. Fedak PWM, de Sa MPL, Verma S, Nili N, Kazemian P, Butany J, Strauss BH, Weisel RD, and David TE. Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. J Thorac Cardiovasc Surg 126: 797-806, 2003.
10. Hooks DA, Tomlinson KA, Marsden SG, LeGrice IJ, Smaill BH, Pullan AJ, and Hunter PJ. Cardiac microstructure: implications for electrical propagation and defibrillation in the heart. Circ Res 91: 331-338, 2002.
11. Iglarz M, Touyz RM, Viel EC, Amiri F, and Schiffrin EL. Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction with the renin-angiotensin system. Am J Hypertens 17: 597-603, 2004.
12. LeGrice IJ, Pope A, and Smaill B. The architecture of the heart: myocyte organization and the cardiac extracellular matrix. In: Interstitial Fibrosis in Heart Failure, edited by Villarreal FJ, 2005, New York: Springer, p. 3-21.
13. Li JM and Shah AM. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 287: R1014-R1030, 2004.
14. A-NADPH oxidase pathway in low-renin hypertension. Circulation 107: 1053-1058, 2003.
15. Nakano D, Itoh C, Ishii F, Kawanishi H, Takaoka M, Kiso Y, Tsuruoka N, Tanaka T, and Matsumara Y. Effects of sesamin on aortic oxidative stress and endothelial dysfunction in deoxycorticosterone acetate-salt hypertensive rats. Biol Pharm Bull 26: 1701-1705, 2003.
16. Norton GR, Tsotetsi J, Trifunovic B, Hartford C, Candy GP, and Woodiwiss AJ. Myocardial stiffness is attributed to alterations in crosslinked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats. Circulation 96: 1991-1998, 1997.
17. Siwik DA, Pagano PJ, and Colucci WS. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol 280: C53-C60, 2001.
18. Sun Y and Weber KT. Infarct scar: a dynamic tissue. Cardiovasc Res 46: 250-256, 2000.
19. Sun Y and Weber KT. RAS and connective tissue in the heart. Int J Biochem Cell Biol 35: 919-931, 2003.
20. Weber KT. From inflammation to fibrosis: a stiff stretch of highway. Hypertension 43: 716-719, 2004.
21. Weber KT, Sun Y, Katwa LC, and Cleutjens JP. Connective tissue: a metabolic entity? J Mol Cell Cardiol 27: 107-120, 1995.
22. Weber KT, Sun Y, Tyagi SC, and Cleutjens JPM. Collagen network of the myocardium: function, structural remodelling and regulatory mechanisms. J Mol Cell Cardiol 26: 279-292, 1994.